99% Savings - Buy Just @1 Rs X
Gravidol 200 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of High BP. The alternative uses of Gravidol 200 Tablet have also been explained below.
The right dosage of Gravidol 200 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Gravidol 200 Tablet as well, which are listed below. Normally, these side effects of Gravidol 200 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Gravidol 200 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Gravidol 200 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Gravidol 200 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) are examples of such conditions. Other contraindications of Gravidol 200 Tablet have been discussed in the sections ahead.
Drug reaction of Gravidol 200 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Gravidol 200 Tablet is not safe while driving, and is not addiction.
Gravidol 200 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Geriatric |
|
Adult |
|
Is the use of Gravidol 200 Tablet safe for pregnant women?
Gravidol shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Gravidol 200 Tablet safe during breastfeeding?
Gravidol may have very limited harmful effects for breastfeeding women.
What is the effect of Gravidol 200 Tablet on the Kidneys?
Gravidol does not damage the kidneys.
What is the effect of Gravidol 200 Tablet on the Liver?
Side effects of Gravidol rarely affect the liver.
What is the effect of Gravidol 200 Tablet on the Heart?
Side effects of Gravidol rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Gravidol 200 Tablet unless your doctor advises you to do so -
Is this Gravidol 200 Tablet habit forming or addictive?
Forming a habit of Gravidol 200 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Gravidol 200 Tablet, you should not drive or work on any heavy machine, as Gravidol 200 Tablet can make you drowsy.
Is it safe?
Yes, but consume Gravidol 200 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Gravidol 200 Tablet is not used to treat mental disorders.
Interaction between Food and Gravidol 200 Tablet
Eating certain foods may increase the time it takes Gravidol 200 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Gravidol 200 Tablet
Consuming Gravidol 200 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trandate® (labetalol hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 735-737